Benign prostatic hyperplasia - Nursing Case Study

Pathophysiology

• Primary mechanism: Benign prostatic hyperplasia (BPH) primarily involves hormonal changes, particularly an increase in dihydrotestosterone (DHT), a potent androgen derived from testosterone, which stimulates prostate cell proliferation and leads to enlargement of the prostate gland.

• Secondary mechanism: Aging contributes to increased estrogen levels relative to testosterone in men, further promoting prostate tissue growth by sensitizing prostate cells to the effects of DHT.

• Key complication: The enlarged prostate compresses the urethra, leading to obstructive urinary symptoms such as difficulty in urination and incomplete bladder emptying, which may potentially progress to urinary retention and increased risk of urinary tract infections.

Patient Profile

Demographics:

67, male, retired civil engineer

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Benign Prostatic Hyperplasia diagnosed 3 years ago

• Current medications: Metformin, Lisinopril, Tamsulosin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased difficulty in urination and nocturia

• Key symptoms: Frequent urination, weak urine stream, urinary urgency, occasional blood in urine, feeling of incomplete bladder emptying

• Vital signs: Blood pressure 150/95 mmHg, Heart rate 88 bpm, Respiratory rate 18 breaths per minute, Temperature 98.6°F

Section 1

As Mr. Thompson continues to experience worsening urinary symptoms, his healthcare provider considers further diagnostic evaluation to better understand the progression of his benign prostatic hyperplasia (BPH). A recent urinalysis shows microscopic hematuria, which aligns with Mr. Thompson's reports of occasional blood in the urine. Additionally, a post-void residual test reveals that Mr. Thompson retains approximately 150 mL of urine after voiding, indicating significant bladder outlet obstruction. These findings suggest that the degree of obstruction has increased, potentially raising the risk for urinary retention and urinary tract infections.

To gain further insights into the severity of prostate enlargement, a transrectal ultrasound is performed. The ultrasound reveals that Mr. Thompson’s prostate gland has increased in size, measuring approximately 60 grams, up from 45 grams noted at his initial diagnosis three years ago. The increase in size corroborates the clinical picture of worsening obstructive symptoms. Simultaneously, a prostate-specific antigen (PSA) test is conducted, showing an elevated level of 6.5 ng/mL, though still within the range expected for BPH, rather than prostate cancer.

Given these developments, Mr. Thompson's treatment plan is re-evaluated. Although he is already on Tamsulosin, a medication that helps to relax the muscles in the prostate and bladder neck to ease urination, his current symptoms suggest that additional therapeutic strategies may be necessary. Consideration is given to starting a 5-alpha-reductase inhibitor to reduce prostate size over time. However, the possibility of acute urinary retention and the need for surgical intervention also become part of the discussion. The healthcare team encourages Mr. Thompson to weigh these options and consider potential next steps, including lifestyle modifications and further monitoring of symptoms. This decision-making process emphasizes the need for balancing medication efficacy with potential side effects and the impact on Mr. Thompson’s quality of life.

Section 2

As Mr. Thompson considers the proposed adjustments to his treatment plan, he begins experiencing new symptoms that prompt an urgent reassessment. One evening, he notices a sudden inability to urinate, accompanied by significant discomfort in his lower abdomen. Recognizing the potential for acute urinary retention, Mr. Thompson contacts his healthcare provider and is advised to visit the emergency department for immediate evaluation.

Upon arrival, the initial assessment reveals that Mr. Thompson is in mild distress due to the inability to void. His vital signs are stable, with a blood pressure of 128/84 mmHg, heart rate of 82 beats per minute, respiratory rate of 18 breaths per minute, and temperature of 98.6°F. Physical examination indicates a distended bladder, palpable just above the pubic symphysis, confirming the suspected urinary retention. A bladder scan shows a post-void residual volume of approximately 450 mL, significantly higher than previously recorded.

The emergency department team initiates a catheterization procedure to relieve the retention and prevent further complications. This intervention successfully drains over 500 mL of urine, providing Mr. Thompson with immediate symptomatic relief. However, the event highlights the progression of his BPH and underscores the need for a more aggressive management approach. In light of these developments, further discussion with Mr. Thompson about surgical options, such as transurethral resection of the prostate (TURP), is warranted. This episode also emphasizes the necessity for careful monitoring and timely intervention to manage potential complications associated with BPH, ensuring that Mr. Thompson maintains his quality of life while minimizing the risk of future adverse events.

Section 3

Following the successful catheterization and symptomatic relief of Mr. Thompson's acute urinary retention, the healthcare team proceeds with further diagnostic evaluations to assess the current state of his benign prostatic hyperplasia and to guide future management decisions. A complete blood count (CBC) and basic metabolic panel are ordered to rule out any underlying infections or renal impairment due to the urinary retention episode. The results reveal an elevated creatinine level of 1.6 mg/dL, indicating mild renal insufficiency potentially linked to prolonged bladder outlet obstruction. The rest of the laboratory values, including electrolytes, are within normal limits, and there is no evidence of infection.

Additionally, a prostate-specific antigen (PSA) test is performed, showing a slight increase to 5.3 ng/mL from his previous value of 4.7 ng/mL. While this elevation does not definitively indicate malignancy, it does suggest a progression in the size or activity of the prostatic tissue, warranting further investigation. An ultrasound of the prostate is conducted, revealing an increase in prostate volume to 60 mL, up from 45 mL at his last assessment three months ago. This significant increase in size correlates with the recent urinary retention episode and supports the consideration of surgical intervention to alleviate his worsening symptoms.

Given these findings, the healthcare team discusses with Mr. Thompson the potential benefits and risks of proceeding with a transurethral resection of the prostate (TURP). This surgical option could provide long-term relief from his obstructive symptoms and prevent future complications such as recurrent urinary retention or kidney damage. Mr. Thompson expresses concern about potential surgical risks but is eager to address the root cause of his symptoms. Together with his healthcare providers, he considers the timing and planning of the procedure, taking into account his current health status, the recent diagnostic findings, and his personal preferences. The team emphasizes the importance of regular follow-up visits post-surgery to monitor his recovery and ensure optimal outcomes.

Section 4

In the days following the discussion about surgical intervention, Mr. Thompson begins to experience increased fatigue and mild breathlessness, symptoms not previously reported. Concerned about these new developments, the healthcare team conducts a thorough assessment. His vital signs reveal a heart rate of 95 beats per minute, blood pressure at 145/90 mmHg, and respiratory rate of 22 breaths per minute. Oxygen saturation remains stable at 96% on room air, yet the elevated respiratory rate alongside the noted fatigue prompts further investigation.

A repeat basic metabolic panel indicates a further increase in creatinine to 1.8 mg/dL, suggesting a progression in renal insufficiency. The team hypothesizes that the ongoing bladder outlet obstruction may be exerting greater strain on his renal function, necessitating prompt intervention. An echocardiogram is ordered to assess cardiac function, given his increased blood pressure and heart rate, which could potentially signify an underlying cardiovascular issue exacerbating his symptoms.

The healthcare team re-evaluates their management plan, considering the urgency of addressing both the prostatic obstruction and the emerging renal and cardiovascular concerns. They discuss the option of an earlier-than-planned TURP to relieve the bladder outlet obstruction and mitigate further renal damage. Mr. Thompson, now more aware of the potential complications arising from his condition, agrees to proceed with the surgery at the earliest convenience. The team plans for the procedure while ensuring that Mr. Thompson is closely monitored for any further changes in his condition, emphasizing the importance of addressing these interconnected health issues comprehensively.

Section 5

As the healthcare team prepares for Mr. Thompson's scheduled TURP, they remain vigilant in monitoring his condition, given the recent developments. On the morning of the procedure, a pre-operative assessment reveals a slight decline in his overall status. Mr. Thompson reports experiencing more pronounced breathlessness than before, especially during minimal exertion, such as walking to the bathroom. His vital signs now show a heart rate of 105 beats per minute and a blood pressure of 150/95 mmHg. Although his oxygen saturation remains stable at 95% on room air, his respiratory rate has increased to 24 breaths per minute. These changes prompt the team to review his recent echocardiogram results, which indicate mild left ventricular hypertrophy and diastolic dysfunction, suggesting that his cardiovascular system is under increased stress.

Further laboratory tests show a slight elevation in his B-type natriuretic peptide (BNP) levels, at 220 pg/mL, hinting at the possibility of early heart failure, likely precipitated by the chronic strain from his prostatic obstruction and subsequent renal challenges. His creatinine level remains at 1.8 mg/dL, underscoring the urgency of the situation. The healthcare team deliberates on the best course of action, weighing the risks and benefits of proceeding with the TURP versus optimizing his cardiovascular status first. They decide on a balanced approach, involving cardiology in the perioperative management to stabilize Mr. Thompson's heart condition as much as possible before surgery.

The interdisciplinary team, including urology, nephrology, and cardiology, collaborates to adjust Mr. Thompson's medications, introducing a low-dose beta-blocker to manage his heart rate and blood pressure, while cautiously optimizing his fluid status to prevent further renal compromise. Mr. Thompson is educated about the importance of adhering to the medication regimen and reporting any worsening symptoms immediately. As the surgical team prepares for the TURP, the focus remains on ensuring that all aspects of Mr. Thompson's health are managed comprehensively, acknowledging the interconnectedness of his prostatic, renal, and cardiovascular conditions. This holistic approach aims to improve his outcomes and set the stage for a smoother recovery post-surgery.